Literature DB >> 10536220

Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study.

C Nemoto1, T Hida, R Arai.   

Abstract

We used triple-labeling immunohistochemistry in rat midbrain sections to identify dopaminergic neurons that contain either one or both of the calcium-binding proteins, calretinin (CR) and calbindin-D28k (CB). Midbrain dopaminergic neurons were immunohistochemically labeled for tyrosine hydroxylase (TH), CR, and CB. In the substantia nigra pars compacta (SNC), TH+/CR+/CB+ cells were clustered in two regions: the dorsal tier of the rostral SNC and the medial part of the intermediate SNC. The ventral tier of the rostral SNC mainly comprised both TH+/CR+/CB- and TH+/CR-/CB- cells. The lateral part of the intermediate SNC and the caudal SNC primarily consisted of TH+/CR-/CB- cells. Throughout the extent of the SNC, approximately half of the TH+ neurons were stained for neither CR nor CB, while the remaining TH+ populations were labeled for CR and/or CB. Throughout the ventral tegmental area, TH+/CR+/CB+ cells, TH+/CR+/CB- cells, TH+/CR-/CB+ cells, and TH+/CR-/CB- cells were found generally scattered, though the TH+/CR-/CB- cells were dominant in number. In the substantia nigra pars lateralis, interfascicular nucleus, and caudal linear nucleus, more than half of the TH+ cells were stained for both CR and CB. In the retrorubral field, two-thirds of the TH+ neurons contained neither protein. The present findings suggest that the SNC can be divided into subcompartments based on the distribution of dopaminergic neurons that contain calcium-binding proteins. Furthermore, because CR and CB likely contribute to calcium homeostasis by buffering intracellular calcium concentrations, midbrain dopaminergic neurons containing one or both of these calcium-binding proteins may have a higher calcium-buffering capacity than those lacking the two proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536220     DOI: 10.1016/s0006-8993(99)01950-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Authors:  Lars M Bjorklund; Rosario Sánchez-Pernaute; Sangmi Chung; Therese Andersson; Iris Yin Ching Chen; Kevin St P McNaught; Anna-Liisa Brownell; Bruce G Jenkins; Claes Wahlestedt; Kwang-Soo Kim; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

2.  Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

Authors:  Sangmi Chung; Kai-C Sonntag; Therese Andersson; Lars M Bjorklund; Jae-Joon Park; Dong-Wook Kim; Un Jung Kang; Ole Isacson; Kwang-Soo Kim
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

3.  Molecular organization and timing of Wnt1 expression define cohorts of midbrain dopamine neuron progenitors in vivo.

Authors:  Ashly Brown; Jason T Machan; Lindsay Hayes; Mark Zervas
Journal:  J Comp Neurol       Date:  2011-10-15       Impact factor: 3.215

Review 4.  Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits.

Authors:  Matthew W Hale; Christopher A Lowry
Journal:  Psychopharmacology (Berl)       Date:  2010-11-19       Impact factor: 4.530

5.  Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons.

Authors:  J Wolfart; H Neuhoff; O Franz; J Roeper
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

6.  Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.

Authors:  Zachary C Baquet; Paula C Bickford; Kevin R Jones
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

7.  Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

Authors:  Ivar Mendez; Rosario Sanchez-Pernaute; Oliver Cooper; Angel Viñuela; Daniela Ferrari; Lars Björklund; Alain Dagher; Ole Isacson
Journal:  Brain       Date:  2005-05-04       Impact factor: 13.501

8.  Forebrain ischemia triggers GABAergic system degeneration in substantia nigra at chronic stages in rats.

Authors:  B Lin; S Levy; A P Raval; M A Perez-Pinzon; R A Defazio
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-10-14

9.  Endogenous calcium buffering capacity of substantia nigral dopamine neurons.

Authors:  R C Foehring; X F Zhang; J C F Lee; J C Callaway
Journal:  J Neurophysiol       Date:  2009-08-12       Impact factor: 2.714

Review 10.  Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.

Authors:  Angela Anderegg; Jean-Francois Poulin; Rajeshwar Awatramani
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.